Blood Testing: Technologies and Global Markets
Report Scope:
This study covers the blood tests that are used routinely for screening, monitoring and evaluating by using analyzers (including automated analyzers) and integrated systems. This report also covers home-monitoring devices and test strips and the associated calibration reagents for diabetes and lipid profiles using finger pricks. The report analyzes and assesses therapeutic and screening applications of blood tests for human conditions such as diabetes, heart disease, autoimmune disorders, cancer, blood disorders, hormonal imbalances, infection and pregnancy. Excluded from this study are urinalysis, urine home diagnostic kits and diagnostic testing such as imaging as well as veterinary blood tests and their analyzers.
The report also includes a discussion of the market’s major drivers and global dynamics along with the political, economic, social and technological factors that impact the market. The report provides market size estimates for the year 2017 (considered as a base year) and 2018, as well as a forecast through 2023. Market estimates and forecast figures are provided for all major market segments. A discussion of the major players is included in the competitive landscape section, which provides trends in product launches, collaborations, mergers and acquisitions, and other agreements.
The report concludes with a special focus on company profiles and includes detailed profiles of the major vendors in the blood testing market.
Report Includes::
This study covers the blood tests that are used routinely for screening, monitoring and evaluating by using analyzers (including automated analyzers) and integrated systems. This report also covers home-monitoring devices and test strips and the associated calibration reagents for diabetes and lipid profiles using finger pricks. The report analyzes and assesses therapeutic and screening applications of blood tests for human conditions such as diabetes, heart disease, autoimmune disorders, cancer, blood disorders, hormonal imbalances, infection and pregnancy. Excluded from this study are urinalysis, urine home diagnostic kits and diagnostic testing such as imaging as well as veterinary blood tests and their analyzers.
The report also includes a discussion of the market’s major drivers and global dynamics along with the political, economic, social and technological factors that impact the market. The report provides market size estimates for the year 2017 (considered as a base year) and 2018, as well as a forecast through 2023. Market estimates and forecast figures are provided for all major market segments. A discussion of the major players is included in the competitive landscape section, which provides trends in product launches, collaborations, mergers and acquisitions, and other agreements.
The report concludes with a special focus on company profiles and includes detailed profiles of the major vendors in the blood testing market.
Report Includes::
- 35 data tables and 43 additional tables
- Country specific data and analysis for US, Canada, Mexico, Germany, France, UK, Italy, Spain, Portugal, China, India, Japan, South Korea and Australia
- Analysis of the global market for blood testing, using quantitative and qualitative approaches
- Description of blood tests that are routinely used for evaluating, screening and monitoring by using analysers (including automated analysers) and integrated systems
- Coverage of methods of extraction of blood for blood testing, and discussion of advantages and disadvantages of blood tests
- Detailed study of the regulatory and reimbursement aspect of the industry
- Insight into current trends and recent developments in the blood testing market
- Comprehensive company profiles of major players in the industry, including Abbott Laboratories, Biomйrieux Marcy L’etoile, F. Hoffman-La Roche Ag, Nova Biomedical Corp., Siemens Healthineers, Thermo Fisher Scientific
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 EXECUTIVE SUMMARY AND HIGHLIGHTS
CHAPTER 3 BLOOD TESTING OVERVIEW
Introduction
Composition of Blood
Blood Plasma
Formed Elements or Corpuscles
Functions of Blood
History of Blood Testing
Types of Blood Testing
Traditional testing
Point of Care Testing (POCT)
Blood Tests
Diagnostic Tests
Screening Panels
Monitoring Tests
Methods of Extraction of Blood for Testing
Venipuncture
Finger Pricking
Arterial Blood Sampling
Advantages of Blood Tests
Disadvantages of Blood Tests
CHAPTER 4 MARKET DYNAMICS
Introduction
Market Drivers
Increasing Incidence of Chronic Diseases and Infections
Advancements in Blood Testing
Rise in the Global Population
Increase in M&A and Agreements Between Companies
Increasing Number of CLIA-Waived Blood Tests in the U.S
Market Restraints
Stringent Regulatory Guidelines
Price Pressure on Manufacturers
Stiff Competition Between Manufacturers
Shortage of Skilled Laboratory Technicians
Market Opportunities
Demand for POC Testing
Demand for Home-Care Monitoring
Emerging Technologies in Blood Testing
Single Blood Drop Tests
Next-Generation Sequencing Tests for Early Cancer Detection
Blood Tests for Brain and Mental Health
Blood Tests for Precision Medicine and Companion Diagnostics
Real-Time DNA Sequencing Technology
CHAPTER 5 MARKET ANALYSIS BY TYPE
Introduction
Overview
Market Size and Forecast
Oncology Tests
Overview
Market Size and Forecast
Hematology Tests
Overview
Market Size and Forecast
Inflammation Tests
Overview
Market Size and Forecast
Toxicology Tests
Overview
Market Size and Forecast
Heart Profile Tests
Overview
Market Size and Forecast
Other Tests
Overview
Market Size and Forecast
CHAPTER 6 MARKET ANALYSIS BY APPLICATION
Introduction
Market Size and Forecast
Prescription Blood Testing Market
Overview
Market Size and Forecast
Cancer Blood Tests
Autoimmune Diseases and Food Allergy Tests
Blood Disorder Blood Tests
Pregnancy Blood Tests
Cardiovascular Disease Blood Tests
Fertility Blood Tests
Kidney Disorder Blood Tests
Diabetes Blood Tests
Liver Disorder Blood Tests
Home Monitoring Blood Testing Market
Overview
Market Size and Forecast
Devices
Test Strips
CHAPTER 7 MARKET ANALYSIS BY REGION
Introduction
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom (U.K.)
France
Italy
Spain and Portugal
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Australia and New Zealand
Rest of Asia-Pacific
Middle East and Africa
Central and South America
CHAPTER 8 TECHNOLOGY OUTLOOK FOR POINT-OF-CARE TESTING
Introduction
Benefits of POC Testing:
Types of Point of Care Blood Testing Equipment
Laboratory Blood Glucose Analyzers
Blood Lactate Analyzers
Cardiac Marker Analyzers
Clinical Chemistry Analyzers
Coagulation analyzers
Creatinine Analyzers
Infectious Disease Analyzers
Blood Gas Analyzers
Technologies Used in POCT
Polymerase Chain Reaction (PCR)
Tandem Mass Spectrometry
Microarray
Gene Sequencing or DNA sequencing
Fluorescence in Situ Hybridization (FISH)
Applications
Emergency
Critical Care
Laboratory
CHAPTER 9 COMPETITIVE LANDSCAPE
Introduction
Porter's Five Forces Analysis
Bargaining Powers of Buyers
Bargaining Power of Suppliers
Threat from New Entrants
Threat from Substitutes
Market Competition
Major Players and Market Share Analysis
New Developments
Key Mergers and Acquisitions
New Products
Key Agreements, Partnerships and Collaborations
CHAPTER 10 REGULATORY AND REIMBURSEMENT SCENARIO
Regulations in the Blood Testing Industry
CLIA-Waived Tests
Recently Approved Blood Tests, Assays, Kits and Devices
Recent Approvals of Medical Devices Cleared Through 510(K)
Recalls
Safety Alerts
Europe
Asia-Pacific
Middle-East and Africa
Central and South America
Reimbursement for Blood Tests
CHAPTER 11 PATENT AND PRODUCT PIPELINE ANALYSIS
Introduction
Patent Analysis
Clinical Trials
CHAPTER 12 COMPANY PROFILES
A. MENARINI DIAGNOSTICS LTD.
Business Overview
ABAXIS GLOBAL DIAGNOSTICS
Business Overview
ABBOTT LABORATORIES
Business Overview
Financials
Products and Services
Developments and Strategies
Business Highlights
AKERS BIOSCIENCES INC.
Business Overview
ANDON HEALTH CO. LTD.
Business Overview
APEX BIOTECHNOLOGY CORP.
Business Overview
ARKRAY USA INC.
Business Overview
BECTON DICKINSON
Business Overview
Financials
Products and Services
Developments and Strategies
Business Highlights
BIOMERIEUX MARCY L'ETOILE
Business Overview
Financials
Products and Services
Developments and Strategies
Business Highlights
BIO-RAD LABORATORIES INC.
Business Overview
DANAHER CORP.
Business Overview
Financials
Products and Services
Developments and Strategies
Business Highlights
DEXCOM INC.
Business Overview
DIASORIN
Business Overview
F. HOFFMAN-LA ROCHE AG
Business Overview
Financials
Products and Services
Developments and Strategies
Business Highlights
GENOMIC HEALTH INC.
Business Overview
GRIFOLS S.A.
Business Overview
HMD BIOMEDICAL INC.
Business Overview
HOLOGIC INC.
Business Overview
IDEAL LIFE Inc.
Business Overview
LIFESCAN INC.
Business Overview
MEDTRONIC INC.
Business Overview
MYRIAD GENETICS
Business Overview
NOVA BIOMEDICAL CORP.
Business Overview
ORTHO CLINICAL DIAGNOSTICS
Business Overview
OSANG HEALTHCARE CO. LTD.
Business Overview
QIAGEN
Business Overview
SIEMENS HEALTHINEERS
Business Overview
Financials
Products and Services
Developments and Strategies
Business Highlights
SYSMEX CORP.
Business Overview
T2 BIOSYSTEMS
Business Overview
THERMO FISHER SCIENTIFIC
Business Overview
Financials
Products and Services
Developments and Strategies
Business Highlights
TRINITY BIOTECH
Business Overview
CHAPTER 13 APPENDIX: ACRONYMS
Acronyms
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 EXECUTIVE SUMMARY AND HIGHLIGHTS
CHAPTER 3 BLOOD TESTING OVERVIEW
Introduction
Composition of Blood
Blood Plasma
Formed Elements or Corpuscles
Functions of Blood
History of Blood Testing
Types of Blood Testing
Traditional testing
Point of Care Testing (POCT)
Blood Tests
Diagnostic Tests
Screening Panels
Monitoring Tests
Methods of Extraction of Blood for Testing
Venipuncture
Finger Pricking
Arterial Blood Sampling
Advantages of Blood Tests
Disadvantages of Blood Tests
CHAPTER 4 MARKET DYNAMICS
Introduction
Market Drivers
Increasing Incidence of Chronic Diseases and Infections
Advancements in Blood Testing
Rise in the Global Population
Increase in M&A and Agreements Between Companies
Increasing Number of CLIA-Waived Blood Tests in the U.S
Market Restraints
Stringent Regulatory Guidelines
Price Pressure on Manufacturers
Stiff Competition Between Manufacturers
Shortage of Skilled Laboratory Technicians
Market Opportunities
Demand for POC Testing
Demand for Home-Care Monitoring
Emerging Technologies in Blood Testing
Single Blood Drop Tests
Next-Generation Sequencing Tests for Early Cancer Detection
Blood Tests for Brain and Mental Health
Blood Tests for Precision Medicine and Companion Diagnostics
Real-Time DNA Sequencing Technology
CHAPTER 5 MARKET ANALYSIS BY TYPE
Introduction
Overview
Market Size and Forecast
Oncology Tests
Overview
Market Size and Forecast
Hematology Tests
Overview
Market Size and Forecast
Inflammation Tests
Overview
Market Size and Forecast
Toxicology Tests
Overview
Market Size and Forecast
Heart Profile Tests
Overview
Market Size and Forecast
Other Tests
Overview
Market Size and Forecast
CHAPTER 6 MARKET ANALYSIS BY APPLICATION
Introduction
Market Size and Forecast
Prescription Blood Testing Market
Overview
Market Size and Forecast
Cancer Blood Tests
Autoimmune Diseases and Food Allergy Tests
Blood Disorder Blood Tests
Pregnancy Blood Tests
Cardiovascular Disease Blood Tests
Fertility Blood Tests
Kidney Disorder Blood Tests
Diabetes Blood Tests
Liver Disorder Blood Tests
Home Monitoring Blood Testing Market
Overview
Market Size and Forecast
Devices
Test Strips
CHAPTER 7 MARKET ANALYSIS BY REGION
Introduction
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom (U.K.)
France
Italy
Spain and Portugal
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Australia and New Zealand
Rest of Asia-Pacific
Middle East and Africa
Central and South America
CHAPTER 8 TECHNOLOGY OUTLOOK FOR POINT-OF-CARE TESTING
Introduction
Benefits of POC Testing:
Types of Point of Care Blood Testing Equipment
Laboratory Blood Glucose Analyzers
Blood Lactate Analyzers
Cardiac Marker Analyzers
Clinical Chemistry Analyzers
Coagulation analyzers
Creatinine Analyzers
Infectious Disease Analyzers
Blood Gas Analyzers
Technologies Used in POCT
Polymerase Chain Reaction (PCR)
Tandem Mass Spectrometry
Microarray
Gene Sequencing or DNA sequencing
Fluorescence in Situ Hybridization (FISH)
Applications
Emergency
Critical Care
Laboratory
CHAPTER 9 COMPETITIVE LANDSCAPE
Introduction
Porter's Five Forces Analysis
Bargaining Powers of Buyers
Bargaining Power of Suppliers
Threat from New Entrants
Threat from Substitutes
Market Competition
Major Players and Market Share Analysis
New Developments
Key Mergers and Acquisitions
New Products
Key Agreements, Partnerships and Collaborations
CHAPTER 10 REGULATORY AND REIMBURSEMENT SCENARIO
Regulations in the Blood Testing Industry
CLIA-Waived Tests
Recently Approved Blood Tests, Assays, Kits and Devices
Recent Approvals of Medical Devices Cleared Through 510(K)
Recalls
Safety Alerts
Europe
Asia-Pacific
Middle-East and Africa
Central and South America
Reimbursement for Blood Tests
CHAPTER 11 PATENT AND PRODUCT PIPELINE ANALYSIS
Introduction
Patent Analysis
Clinical Trials
CHAPTER 12 COMPANY PROFILES
A. MENARINI DIAGNOSTICS LTD.
Business Overview
ABAXIS GLOBAL DIAGNOSTICS
Business Overview
ABBOTT LABORATORIES
Business Overview
Financials
Products and Services
Developments and Strategies
Business Highlights
AKERS BIOSCIENCES INC.
Business Overview
ANDON HEALTH CO. LTD.
Business Overview
APEX BIOTECHNOLOGY CORP.
Business Overview
ARKRAY USA INC.
Business Overview
BECTON DICKINSON
Business Overview
Financials
Products and Services
Developments and Strategies
Business Highlights
BIOMERIEUX MARCY L'ETOILE
Business Overview
Financials
Products and Services
Developments and Strategies
Business Highlights
BIO-RAD LABORATORIES INC.
Business Overview
DANAHER CORP.
Business Overview
Financials
Products and Services
Developments and Strategies
Business Highlights
DEXCOM INC.
Business Overview
DIASORIN
Business Overview
F. HOFFMAN-LA ROCHE AG
Business Overview
Financials
Products and Services
Developments and Strategies
Business Highlights
GENOMIC HEALTH INC.
Business Overview
GRIFOLS S.A.
Business Overview
HMD BIOMEDICAL INC.
Business Overview
HOLOGIC INC.
Business Overview
IDEAL LIFE Inc.
Business Overview
LIFESCAN INC.
Business Overview
MEDTRONIC INC.
Business Overview
MYRIAD GENETICS
Business Overview
NOVA BIOMEDICAL CORP.
Business Overview
ORTHO CLINICAL DIAGNOSTICS
Business Overview
OSANG HEALTHCARE CO. LTD.
Business Overview
QIAGEN
Business Overview
SIEMENS HEALTHINEERS
Business Overview
Financials
Products and Services
Developments and Strategies
Business Highlights
SYSMEX CORP.
Business Overview
T2 BIOSYSTEMS
Business Overview
THERMO FISHER SCIENTIFIC
Business Overview
Financials
Products and Services
Developments and Strategies
Business Highlights
TRINITY BIOTECH
Business Overview
CHAPTER 13 APPENDIX: ACRONYMS
Acronyms
LIST OF TABLES
Summary Table: Global Market for Blood Testing, by Region, Through 2023
Table 1: Composition of Blood Plasma
Table 2: Types of Cellular Elements Present in Blood
Table 3: Brief Development Timeline of Blood Testing, Through 2010
Table 4: Normal Values of Differential WBC Count
Table 5: Countries with the Highest Populations, 2018
Table 6: Recently Waived CLIA Blood Tests, Through July 2018
Table 7: Difference between Traditional Testing and Point-of-Care Testing
Table 8: Selected Companies Manufacturing Single Blood Drop Tests
Table 9: Global Market for Blood Testing, by Type, Through 2023
Table 10: Potential Uses for Cancer Biomarkers
Table 11: Global Market for Oncology Blood Testing, by Region, Through 2023
Table 12: Common Blood Clotting Tests and Normal Values
Table 13: Global Market for Hematology Blood Testing, by Region, Through 2023
Table 14: Global Market for Inflammation Blood Testing, by Region, Through 2023
Table 15: Global Market for Toxicology Blood Testing, by Region, Through 2023
Table 16: Cardiac Biomarker Tests
Table 17: Global Market for Heart Profile Blood Testing, by Region, Through 2023
Table 18: Comprehensive Nutritional Panel Tests
Table 19: Global Market for Other Blood Testing, by Region, Through 2023
Table 20: Global Market for Blood Testing, by Application, Through 2023
Table 21: Global Market for Prescription Blood Testing, by Type, Through 2023
Table 22: Global Market for Prescription Blood Testing, by Region, Through 2023
Table 23: Common Types of Cancer
Table 24: Cancer Biomarkers
Table 25: Global Market for Cancer Blood Testing, by Region, Through 2023
Table 26: Common Autoimmune Diseases
Table 27: Global Market for Autoimmune Blood Testing, by Region, Through 2023
Table 28: Types of Blood Disorders
Table 29: Global Market for Blood Disorder Testing, by Region, Through 2023
Table 30: Infectious Disease Testing in Pregnancy
Table 31: Global Market for Pregnancy Blood Testing, by Region, Through 2023
Table 32: Common Cardiovascular Diseases
Table 33: Global Market for Cardiovascular Blood Testing, by Region, Through 2023
Table 34: Global Market for Fertility Blood Testing, by Region, Through 2023
Table 35: Common Kidney Diseases
Table 36: Blood Tests for Kidney Diseases
Table 37: Global Market for Kidney Blood Testing, by Region, Through 2023
Table 38: Diagnostic Criteria for Diabetes
Table 39: Types of Diabetes
Table 40: Global Market for Diabetes Blood Testing, by Region, Through 2023
Table 41: Global Market for Liver Blood Testing, by Region, Through 2023
Table 42: Global Market for Home Monitoring Blood Testing, by Type, Through 2023
Table 43: Global Market for Home Monitoring Blood Testing, by Region, Through 2023
Table 44: Types of Home Monitoring Devices
Table 45: Global Market for Home Monitoring Devices, by Region, Through 2023
Table 46: Global Market for Home Monitoring Test Strips, by Region, Through 2023
Table 47: Global Market for Blood Testing, by Region, Through 2023
Table 48: North American Market for Blood Testing, by Country, Through 2023
Table 49: Top Five Causes of Death in Mexico, 2005–2016
Table 50: European Market for Blood Testing, by Country, Through 2023
Table 51: Asia-Pacific Market for Blood Testing, by Country, Through 2023
Table 52: Examples of POC Tests
Table 53: Normal Arterial Blood Gas Analysis Parameters
Table 54: Selected Mixed and Complex Acid-Base Disturbances in Blood Gas Analysis
Table 55: Newly Developed Blood Tests and Kits in the Market 2016-2018
Table 56: Recent Approvals of Blood Tests, Assays, Kits and Medical Devices
Table 57: Recent Approvals of Medical Devices Cleared Through 510(k), Februrary 2016-August 2018
Table 58: Recent Recalls of Blood Tests, Assays, Kits and Medical Devices, June 2016 to June 2018
Table 59: Classification of In Vitro Diagnostic Devices Under the European IVDR
Table 60: Blood Testing Patent Review, January 2018 to August 2018
Table 61: Blood Testing Patent Review, January 2017 to October 2017
Table 62: Clinical Trials on Blood Tests, Assays, Kits and Medical Devices
Table 63: Abbott Laboratories Revenue, 2016 and 2017
Table 64: Abbott Laboratories Products and Services
Table 65: Becton Dickinson Revenue, 2016 and 2017
Table 66: Becton Dickinson Products and Services
Table 67: bioMйrieux Revenue, 2016 and 2017
Table 68: bioMйrieux Products and Services
Table 69: Danaher Revenue, 2016 and 2017
Table 70: Danaher Products and Services
Table 71: Roche Group Revenue, 2016 and 2017
Table 72: Roche Products and Services
Table 73: Siemens Healthineers Revenue, 2016 and 2017
Table 74: Siemens Products and Services
Table 75: Thermo Fisher Revenue, 2016 and 2017
Table 76: Thermo Fisher Products and Services
Table 77: Acronyms Used in This Report
Summary Table: Global Market for Blood Testing, by Region, Through 2023
Table 1: Composition of Blood Plasma
Table 2: Types of Cellular Elements Present in Blood
Table 3: Brief Development Timeline of Blood Testing, Through 2010
Table 4: Normal Values of Differential WBC Count
Table 5: Countries with the Highest Populations, 2018
Table 6: Recently Waived CLIA Blood Tests, Through July 2018
Table 7: Difference between Traditional Testing and Point-of-Care Testing
Table 8: Selected Companies Manufacturing Single Blood Drop Tests
Table 9: Global Market for Blood Testing, by Type, Through 2023
Table 10: Potential Uses for Cancer Biomarkers
Table 11: Global Market for Oncology Blood Testing, by Region, Through 2023
Table 12: Common Blood Clotting Tests and Normal Values
Table 13: Global Market for Hematology Blood Testing, by Region, Through 2023
Table 14: Global Market for Inflammation Blood Testing, by Region, Through 2023
Table 15: Global Market for Toxicology Blood Testing, by Region, Through 2023
Table 16: Cardiac Biomarker Tests
Table 17: Global Market for Heart Profile Blood Testing, by Region, Through 2023
Table 18: Comprehensive Nutritional Panel Tests
Table 19: Global Market for Other Blood Testing, by Region, Through 2023
Table 20: Global Market for Blood Testing, by Application, Through 2023
Table 21: Global Market for Prescription Blood Testing, by Type, Through 2023
Table 22: Global Market for Prescription Blood Testing, by Region, Through 2023
Table 23: Common Types of Cancer
Table 24: Cancer Biomarkers
Table 25: Global Market for Cancer Blood Testing, by Region, Through 2023
Table 26: Common Autoimmune Diseases
Table 27: Global Market for Autoimmune Blood Testing, by Region, Through 2023
Table 28: Types of Blood Disorders
Table 29: Global Market for Blood Disorder Testing, by Region, Through 2023
Table 30: Infectious Disease Testing in Pregnancy
Table 31: Global Market for Pregnancy Blood Testing, by Region, Through 2023
Table 32: Common Cardiovascular Diseases
Table 33: Global Market for Cardiovascular Blood Testing, by Region, Through 2023
Table 34: Global Market for Fertility Blood Testing, by Region, Through 2023
Table 35: Common Kidney Diseases
Table 36: Blood Tests for Kidney Diseases
Table 37: Global Market for Kidney Blood Testing, by Region, Through 2023
Table 38: Diagnostic Criteria for Diabetes
Table 39: Types of Diabetes
Table 40: Global Market for Diabetes Blood Testing, by Region, Through 2023
Table 41: Global Market for Liver Blood Testing, by Region, Through 2023
Table 42: Global Market for Home Monitoring Blood Testing, by Type, Through 2023
Table 43: Global Market for Home Monitoring Blood Testing, by Region, Through 2023
Table 44: Types of Home Monitoring Devices
Table 45: Global Market for Home Monitoring Devices, by Region, Through 2023
Table 46: Global Market for Home Monitoring Test Strips, by Region, Through 2023
Table 47: Global Market for Blood Testing, by Region, Through 2023
Table 48: North American Market for Blood Testing, by Country, Through 2023
Table 49: Top Five Causes of Death in Mexico, 2005–2016
Table 50: European Market for Blood Testing, by Country, Through 2023
Table 51: Asia-Pacific Market for Blood Testing, by Country, Through 2023
Table 52: Examples of POC Tests
Table 53: Normal Arterial Blood Gas Analysis Parameters
Table 54: Selected Mixed and Complex Acid-Base Disturbances in Blood Gas Analysis
Table 55: Newly Developed Blood Tests and Kits in the Market 2016-2018
Table 56: Recent Approvals of Blood Tests, Assays, Kits and Medical Devices
Table 57: Recent Approvals of Medical Devices Cleared Through 510(k), Februrary 2016-August 2018
Table 58: Recent Recalls of Blood Tests, Assays, Kits and Medical Devices, June 2016 to June 2018
Table 59: Classification of In Vitro Diagnostic Devices Under the European IVDR
Table 60: Blood Testing Patent Review, January 2018 to August 2018
Table 61: Blood Testing Patent Review, January 2017 to October 2017
Table 62: Clinical Trials on Blood Tests, Assays, Kits and Medical Devices
Table 63: Abbott Laboratories Revenue, 2016 and 2017
Table 64: Abbott Laboratories Products and Services
Table 65: Becton Dickinson Revenue, 2016 and 2017
Table 66: Becton Dickinson Products and Services
Table 67: bioMйrieux Revenue, 2016 and 2017
Table 68: bioMйrieux Products and Services
Table 69: Danaher Revenue, 2016 and 2017
Table 70: Danaher Products and Services
Table 71: Roche Group Revenue, 2016 and 2017
Table 72: Roche Products and Services
Table 73: Siemens Healthineers Revenue, 2016 and 2017
Table 74: Siemens Products and Services
Table 75: Thermo Fisher Revenue, 2016 and 2017
Table 76: Thermo Fisher Products and Services
Table 77: Acronyms Used in This Report
LIST OF FIGURES
Summary Figure: Global Market for Blood Testing, by Region, 2017-2023
Figure 1: Functions of Blood
Figure 2: Global Causes of Death, 2016
Figure 3: HIV Infected Population, by Region, 2016
Figure 4: Projected World Population, by Country, 2050
Figure 5: Projected Increase in Workforce Needs in the U.S., 2016 and 2026
Figure 6: Global Market for Blood Testing, by Type, 2017-2023
Figure 7: Global Market for Oncology Blood Testing, by Region, 2017-2023
Figure 8: Global Market for Hematology Blood Testing, by Region, 2017-2023
Figure 9: Global Market for Inflammation Blood Testing, by Region, 2017-2023
Figure 10: Global Market for Toxicology Blood Testing, by Region, 2017-2023
Figure 11: Mortality Rate from Cardiovascular Diseases in the U.S., 2015
Figure 12: Global Market for Heart Profile Blood Testing, by Region, 2017-2023
Figure 13: Global Market for Other Blood Testing, by Region, 2017-2023
Figure 14: Global Market for Blood Testing, by Application, 2017-2023
Figure 15: Global Market for Prescription Blood Testing, by Type, 2017-2023
Figure 16: Global Market for Prescription Blood Testing, by Region, 2017-2023
Figure 17: Global Market for Cancer Blood Testing, by Region, 2017-2023
Figure 18: Global Market for Autoimmune Blood Testing, by Region, 2017-2023
Figure 19: Estimated New Cases of Leukemia, Myeloma and Lymphoma, 2018
Figure 20: Global Market for Blood Disorder Testing, by Region, 2017-2023
Figure 21: Global Market for Pregnancy Blood Testing, by Region, 2017-2023
Figure 22: Cardiovascular Disease Mortality, by Disease Area, 2017
Figure 23: Global Market for Cardiovascular Blood Testing, by Region, 2017-2023
Figure 24: Global Market for Fertility Blood Testing, by Region, 2017-2023
Figure 25: Causes of End Stage Renal Disease in the U.S., 2014
Figure 26: Global Market for Kidney Blood Testing, by Region, 2017-2023
Figure 27: Global Market for Diabetes Blood Testing, by Region, 2017-2023
Figure 28: Global Market for Liver Blood Testing, by Region, 2017-2023
Figure 29: Prevalence of Diabetes, by Region, 2017 and 2045
Figure 30: Global Market for Home Monitoring Blood Testing, by Type, 2017-2023
Figure 31: Global Market for Home Monitoring Blood Testing, by Region, 2017-2023
Figure 32: Global Market for Home Monitoring Devices, by Region, 2017-2023
Figure 33: Global Market for Home Monitoring Test Strips, by Region, 2017-2023
Figure 34: Global Market for Blood Testing, by Region, 2017-2023
Figure 35: North American Market for Blood Testing, 2017-2023
Figure 36: North American Market for Blood Testing, by Country, 2017-2023
Figure 37: European Market for Blood Testing, 2017-2023
Figure 38: European Market for Blood Testing, by Country, 2017-2023
Figure 39: Asia-Pacific Market for Blood Testing, 2017-2023
Figure 40: Asia-Pacific Market for Blood Testing, by Country, 2017-2023
Figure 41: Middle Eastern and African Market for Blood Testing, 2017-2023
Figure 42: Central and South American Market for Blood Testing, 2017-2023
Figure 43: Steps in Blood Gas Interpretation
Figure 44: Bargaining Power of Buyers in the Blood Testing Industry
Figure 45: Bargaining Power of Suppliers in the Blood Testing Industry
Figure 46: Threat from New Entrants in the Blood Testing Industry
Figure 47: Threat from Substitutes in the Blood Testing Industry
Figure 48: Market Competition in the Blood Testing Industry
Figure 49: Global Market Share of Major Players in the Blood Testing Industry, 2017
Figure 50: Abbott Laboratories Revenue, by Segment, 2017
Figure 51: Becton Dickinson Revenue Share, by Segment, 2017
Figure 52: Becton Dickinson Revenue Share, by Country/Region, 2017
Figure 53: bioMйrieux Revenue Share, by Segment, 2017
Figure 54: bioMйrieux Revenue Share, by Region, 2017
Figure 55: bioMйrieux R&D Investment, 2016 and 2017
Figure 56: Danaher Life Sciences Revenue Share, by Segment, 2017
Figure 57: Danaher Life Sciences Revenue Share, by Region, 2017
Figure 58: Danaher Revenue Share, by Segment, 2017
Figure 59: Roche Diagnostics Top Selling Products Revenue, 2017
Figure 60: Roche Group R&D Expenditure, 2016 and 2017
Figure 61: Siemens AG R&D Expenditure, 2016 and 2017
Figure 62: Thermo Fisher Revenue Share, by Segment, 2017
Figure 63: Thermo Fisher Revenue Share, by Region, 2017
Summary Figure: Global Market for Blood Testing, by Region, 2017-2023
Figure 1: Functions of Blood
Figure 2: Global Causes of Death, 2016
Figure 3: HIV Infected Population, by Region, 2016
Figure 4: Projected World Population, by Country, 2050
Figure 5: Projected Increase in Workforce Needs in the U.S., 2016 and 2026
Figure 6: Global Market for Blood Testing, by Type, 2017-2023
Figure 7: Global Market for Oncology Blood Testing, by Region, 2017-2023
Figure 8: Global Market for Hematology Blood Testing, by Region, 2017-2023
Figure 9: Global Market for Inflammation Blood Testing, by Region, 2017-2023
Figure 10: Global Market for Toxicology Blood Testing, by Region, 2017-2023
Figure 11: Mortality Rate from Cardiovascular Diseases in the U.S., 2015
Figure 12: Global Market for Heart Profile Blood Testing, by Region, 2017-2023
Figure 13: Global Market for Other Blood Testing, by Region, 2017-2023
Figure 14: Global Market for Blood Testing, by Application, 2017-2023
Figure 15: Global Market for Prescription Blood Testing, by Type, 2017-2023
Figure 16: Global Market for Prescription Blood Testing, by Region, 2017-2023
Figure 17: Global Market for Cancer Blood Testing, by Region, 2017-2023
Figure 18: Global Market for Autoimmune Blood Testing, by Region, 2017-2023
Figure 19: Estimated New Cases of Leukemia, Myeloma and Lymphoma, 2018
Figure 20: Global Market for Blood Disorder Testing, by Region, 2017-2023
Figure 21: Global Market for Pregnancy Blood Testing, by Region, 2017-2023
Figure 22: Cardiovascular Disease Mortality, by Disease Area, 2017
Figure 23: Global Market for Cardiovascular Blood Testing, by Region, 2017-2023
Figure 24: Global Market for Fertility Blood Testing, by Region, 2017-2023
Figure 25: Causes of End Stage Renal Disease in the U.S., 2014
Figure 26: Global Market for Kidney Blood Testing, by Region, 2017-2023
Figure 27: Global Market for Diabetes Blood Testing, by Region, 2017-2023
Figure 28: Global Market for Liver Blood Testing, by Region, 2017-2023
Figure 29: Prevalence of Diabetes, by Region, 2017 and 2045
Figure 30: Global Market for Home Monitoring Blood Testing, by Type, 2017-2023
Figure 31: Global Market for Home Monitoring Blood Testing, by Region, 2017-2023
Figure 32: Global Market for Home Monitoring Devices, by Region, 2017-2023
Figure 33: Global Market for Home Monitoring Test Strips, by Region, 2017-2023
Figure 34: Global Market for Blood Testing, by Region, 2017-2023
Figure 35: North American Market for Blood Testing, 2017-2023
Figure 36: North American Market for Blood Testing, by Country, 2017-2023
Figure 37: European Market for Blood Testing, 2017-2023
Figure 38: European Market for Blood Testing, by Country, 2017-2023
Figure 39: Asia-Pacific Market for Blood Testing, 2017-2023
Figure 40: Asia-Pacific Market for Blood Testing, by Country, 2017-2023
Figure 41: Middle Eastern and African Market for Blood Testing, 2017-2023
Figure 42: Central and South American Market for Blood Testing, 2017-2023
Figure 43: Steps in Blood Gas Interpretation
Figure 44: Bargaining Power of Buyers in the Blood Testing Industry
Figure 45: Bargaining Power of Suppliers in the Blood Testing Industry
Figure 46: Threat from New Entrants in the Blood Testing Industry
Figure 47: Threat from Substitutes in the Blood Testing Industry
Figure 48: Market Competition in the Blood Testing Industry
Figure 49: Global Market Share of Major Players in the Blood Testing Industry, 2017
Figure 50: Abbott Laboratories Revenue, by Segment, 2017
Figure 51: Becton Dickinson Revenue Share, by Segment, 2017
Figure 52: Becton Dickinson Revenue Share, by Country/Region, 2017
Figure 53: bioMйrieux Revenue Share, by Segment, 2017
Figure 54: bioMйrieux Revenue Share, by Region, 2017
Figure 55: bioMйrieux R&D Investment, 2016 and 2017
Figure 56: Danaher Life Sciences Revenue Share, by Segment, 2017
Figure 57: Danaher Life Sciences Revenue Share, by Region, 2017
Figure 58: Danaher Revenue Share, by Segment, 2017
Figure 59: Roche Diagnostics Top Selling Products Revenue, 2017
Figure 60: Roche Group R&D Expenditure, 2016 and 2017
Figure 61: Siemens AG R&D Expenditure, 2016 and 2017
Figure 62: Thermo Fisher Revenue Share, by Segment, 2017
Figure 63: Thermo Fisher Revenue Share, by Region, 2017
